Skip to main content
. 2021 Sep 24;13(19):4772. doi: 10.3390/cancers13194772
BMI body mass index
PHC perihilar cholangiocarcinoma
HPB hepato-pancreato-biliary
WHO World Health Organization
RFS recurrence-free survival
EU European region
AJCC American Joint Committee on Cancer
UICC International Union Against Cancer
CT computed tomography
MRI magnetic resonance imaging
MRCP magnetic resonance cholangiopancreatography
EBD endoscopic biliary drainage
PTBD percutaneous transhepatic biliary drainage
PVE portal vein embolization
CLR caudate lobe resection
CEA carcinoembryonic antigen
CA 19-9 cancer antigen 19-9
ASA American society of anesthesiologists
TNM tumor node metastasis
ANOVA analysis of variance
RI recurrence interval
RFS recurrence free survival
HR hazard ratio
CI confidence interval
HCC hepatocellular carcinoma
iCCA intrahepatic cholangiocarcinoma
NASH non-alcoholic steatohepatitis
NAFLD non-alcoholic fatty liver disease
eCCA extrahepatic cholangiocarcinoma